Sagility India Limited has informed the Exchange about Investor Presentation
Date: February 05, 2025
To, The Manager Listing Department National Stock Exchange (NSE) Exchange Plaza, 5th Floor Plot No. C/1, G-Block Bandra-Kurla Complex Bandra (E), Mumbai - 400 051 Symbol: SAGILITY
Dear Sir/Ma’am,
To, The Manager Listing Department Bombay Stock Exchange (BSE) Phiroze Jeejeebhoy Towers Dalal Street Mumbai - 400 001 Scrip Code:544282
Subject: Submission of Investor Presentation to be made to investors on February 05, 2025, pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
In continuation to our letter dated January 31, 2025, we are enclosing herewith the presentation to be made to Investors on the Financial Results of Sagility India Limited for the quarter ended December 31, 2024, scheduled today i.e., on Wednesday, 05th December 2025 at 7:00PM (IST).
The details are also being made available on the Company’s website www.sagilityhealth.com
This is for your kind information and record.
Thanking You,
For Sagility India Limited
Satishkumar Sakharayapattana Seetharamaiah Company Secretary & Compliance Officer M. No: A16008
Encl: a/a
Sagility India Limited (Formerly Sagility India Private Limited) Registered Office - No. 23 & 24, AMR Tech Park, Building 2A, First Floor Hongasandara Village, Off Hosur Road, Bommanahalli, Bengaluru – 560068 Karnataka India Corporate Identity Number: U72900KA2021PLC150054 Tel. No.: 080-71251500, Website: www.SagilityHealth.com
Feb 5, 2025
Investor Deck – Q3 FY25
Safe Harbour
Certain statements in this release concerning Sagility’ future growth prospects may be seen as forward- looking statements, which involve a number of risks and uncertainties that could cause the actuals to differ materially from such statements. Sagility does not undertake to update any such statement that may have been made from time to time by or on behalf of the company..
2
Key Highlights Q3 FY25 Highlights
YTD Dec FY25 Highlights
► Revenue in Q3 at ₹14,531 million, grew by ₹1,929 million Y-o-Y
► Revenue in YTD Dec’24 at ₹ 40,014 million grew by ₹5,311 million
(corresponding to 15.3% growth Y-o-Y and 14.0% at constant currency)
Y-o-Y (corresponding to 15.3% growth Y-o-Y and 13.9% at
► Adjusted EBITDA at ₹4,567 million, grew by ₹1,837 million Y-o-Y
constant currency)
(corresponding to 67.3% growth Y-o-Y )
► Adjusted EBITDA at ₹11,104 million, grew by ₹2,578 million Y-o-Y
► Adjusted PAT at ₹2,626 million, grew by ₹ 1,059 million Y-o-Y
(corresponding to 30.2% growth Y-o-Y )
(corresponding to 67.6% growth Y-o-Y )
► Adjusted PAT at ₹5,709 million, grew by ₹1,464 million Y-o-Y
(corresponding to 34.5% growth Y-o-Y )
Key Business Highlights
► Robust year-on-year growth, largely fueled by our tenured existing clients and logos that we had onboarded the last couple of years.
► Our tech and transformation led services utilizing automation, analytics, and GenAI — has substantially strengthened our client relationships and
positioned us as a trusted strategic and advisory partner. This shift has been pivotal in driving growth and elevating our market perception amongst
clients.
► Recent acquisition of BroadPath strengthens Sagility’s position among the top ten largest health plans in the US, while also adding 30+ mid-market
clients to our portfolio
► Operations remain robust, driven by strong performance across key metrics
► People: Global headcount stands at 39,595 as of December 2024.
► 1,215 employees added during Q3 FY25 (3.2% Q-o-Q growth in headcount).
► Attrition low at 21.8%*
* Voluntary attrition considering employees who were employees for more than 90 days (%) on an annualized basis
3
KPIs
Amt in INR M
KPI
Q3 FY25
Q2 FY25
Q3 FY24
Y-o-Y %
YTD Dec FY25
YTD Dec FY24
Y-o-Y %
Revenue from Operation
14,531
13,250
12,602
15.3%
40,014
34,704
15.3%
Revenue by Vertical split
By Payer %
By Provider %
89.3%
10.7%
89.2%
10.8%
91.1%
8.9%
89.2%
10.8%
90.0%
10.0%
Growth in revenue from Operation (%)
15.3%
21.1%
17.6%
15.3%
13.4%
Adjusted EBITDA
Adjusted EBITDA %
Adjusted PAT
Adjusted PAT %
4,567
31.4%
2626
18.1%
3,378
25.5%
1636
12.3%
2,730
21.7%
1567
12.4%
67.3%
67.6%
Total Number of Employees
39,595
38,380
36,639
Voluntary attrition rate* (%)
21.8%
25.8%
21.2%
11,104
27.8%
5,709
14.3%
39,595
24.8%
8,527
24.6%
4,245
12.2%
36,639
25.2%
30.2%
34.5%
8.1%
*considering employees who were employees for more than 90 days (%) on an annualized basis
4
About BroadPath Healthcare Solutions
► Founded in 2008, headquartered in Tucson, Arizona, US.
► BroadPath is a Healthcare focused services company
► BroadPath services portfolio includes member engagement,
member acquisition, claims and appeals administration, provider enrolment and credentialing.
► Strong portfolio of clients including several mid-market clients
► Strong NPS amongst the clients.
► Pioneer in the work-from-home model even before the COVID-19
pandemic
► Bhive is their proprietary platform designed to enhance
employee engagement and optimize operational metrics in a remote work environment
30+ Customers
1,600+ employees
US and Philippines
Revenues ~$70M+ for CY24
Compelling Strategic and Financial rationale
Increased presence in Top 10 payers
Diversified Client Base
Expanded Capabilities
► Add another top 10 US payer to our
► Access to 30+ mid-market clients
list of clients
► Expand footprint with other two existing Top 10 payer clients
► Post-acquisition, serve six Top 10 U.S. payers, strengthening our leadership in the large payer segment
Financial Synergies
► Improved efficiency by scaling Sagility’s onshore operations.
► Opportunity to cross-sell broader
services that Sagility offers.
► Diversifies revenue base across client
segments
► Expand service offerings across the Payer value chain with enhanced Medicare & Medicaid member acquisition and enrolment services
► Sagility’s multi-shore delivery model adds significant value to BroadPath clients
Enhancing Engagement & Efficiency with Bhive
Talent Acquisition
► Enhanced productivity with Bhive
► 1600+ employees with strong
platform
► Reduced combined administrative
► Integrating Bhive with Sagility’s GenAI
costs
► Increase sales efficiency and
resource utilization
solutions to drive operational efficiencies
operational expertise in a work-from- home delivery model
► Strengthen sales, marketing, and account management with strong market facing team
Acquisition to be EPS accretive from Day one. Funded 100% from Cash.
Financial Highlights
Highlights
Strong Q3 and YTD Dec FY25 Performance
Q3 FY25 Financial Highlights
YTD Dec FY25 Financial Highlights
► Q3 FY25 revenue stood at ₹14,531 Million ($172.0 M)
► YTD Dec FY25 revenue stood at ₹40,014 Million ($476.5 M)
► 15.3% growth Y-o-Y (14.0% at constant currency ) ► 9.7% growth Q-o-Q (9.0% at constant currency)
► 15.3% growth Y-o-Y (13.9% at constant currency )
► Adjusted EBITDA at ₹4,567 Million ($54.1 M) ► Adjusted EBITDA Margin : 31.4% ► 67.3% growth Y-o-Y; 35.2% growth Q-o-Q ► Includes Other income of ₹440 Million ($5.2 M)
► Adjusted EBITDA at ₹11,104 Million ($132.2 M) ► Adjusted EBITDA Margin : 27.8% ► 30.2% growth Y-o-Y ► Includes Other income of ₹596 Million ($7.1 M)
► Adjusted PAT at ₹2,626 Million ($31.1 M) ► Adjusted PAT Margin: 18.1% ► 67.6% growth Y-o-Y; 60.5% growth Q-o-Q
► Adjusted PAT at ₹5,709 Million ($68.0 M) ► Adjusted PAT Margin : 14.3 % ► 34.5% growth Y-o-Y
► OCF ₹3,043 Million ($ 36.0 M) ► 69.8% of EBITDA
► OCF ₹9,132 Million ($108.7 M) ► 94.0% of EBITDA
8
Quarter wise performance
₹15.0
₹14.0
Headcount (‘000)
₹13.0
₹12.0
₹11.0
4 2 Y F
₹10.0
₹9.0
33.5
36.5
₹11.2
12.8%
₹10.9
11.5%
Q1 FY24
Q2 FY24
36.6
₹12.6
12.4%
Q3 FY24
Revenue INR B
Adjusted PAT %
35.0
₹12.8
12.9%
Q4 FY24
Headcount (‘000)
35.8
₹15.0
₹14.0
₹13.0
₹12.0
₹11.0
5 2 Y F
₹10.0
₹9.0
₹12.2
11.8%
Q1 FY25
38.3
₹13.3
12.3%
Q2 FY25
39.6
₹14.5
18.1%
Revenue INR B
Adjusted PAT %
Q3 FY25
Q4 FY25
Q3 FY25 - High PAT driven by higher Other income led by high Forex gain and higher margins during Open enrollment season.
40.0%
35.0%
30.0%
25.0%
20.0%
15.0%
10.0%
5.0%
0.0%
40.0%
35.0%
30.0%
25.0%
20.0%
15.0%
10.0%
5.0%
0.0%
Financial performance snapshot – Q3 FY25
Revenue (INR Million)
Y-o-Y
15.3%
₹12,602
₹13,250
Q-o-Q
9.7%
₹14,531
Adjusted EBITDA (INR Million)
Y-o-Y
67.3%
Q-o-Q
35.2%
₹4,567
Adjusted PAT (INR Million)
Y-o-Y
67.6%
Q-o-Q
60.5%
₹2,626
₹2,730
₹3,378
₹1,567
₹1,636
Q3'24
Q2'25
Q3'25
Q3'24
Q2'25
Q3'25
Q3'24
Q2'25
Q3'25
Revenue ($M)
$150.8
Q-o-Q
9.0%
$172.0
Y-o-Y
14.0%
$157.9
Adjusted EBITDA ($M)
Y-o-Y
65.8%
$40.3
Q-o-Q
34.4%
$54.1
Adjusted PAT ($M)
Y-o-Y
66.0%
Q-o-Q
59.7%
$31.1
$32.6
$18.8
$19.5
Q3'24
Q2'25
Q3'25
Q3'24
Q2'25
Q3'25
Q3'24
Q2'25
Q3'25
10
Financial performance snapshot – Long Term
Revenue (INR Million)
FY24 YoY% YTD Dec YoY%
12.7%
15.3%
Adjusted EBITDA (INR Million)
FY24 YoY% YTD Dec YoY%
12.1%
30.2%
Adjusted PAT (INR Million)
FY24 YoY% YTD Dec YoY%
29.4%
34.5%
₹42,184
₹47,536
₹34,704
₹40,014
₹10,449
₹11,715
₹11,104
₹8,527
₹5,896
₹5,709
₹4,556
₹4,245
FY'23
FY'24
YTD Dec'23
YTD Dec'24
FY'23
FY'24
YTD Dec'23
YTD Dec'24
FY'23
FY'24
YTD Dec'23
YTD Dec'24
Revenue ($M)
FY24 YoY% YTD Dec YoY%
10.5%
13.9%
Adjusted EBITDA ($M)
FY24 YoY% YTD Dec YoY%
10.0%
28.6%
Adjusted PAT ($M)
FY24 YoY% YTD Dec YoY%
27.0%
32.8%
$518.2
$572.9
$418.5
$476.5
$128.4
$141.2
$132.2
$71.1
$68.0
$102.8
$56.0
$51.2
FY'23
FY'24
YTD Dec'23
YTD Dec'24
FY'23
FY'24
YTD Dec'23
YTD Dec'24
FY'23
FY'24
YTD Dec'23
YTD Dec'24
11
Financial Indicators
Adjusted EPS (in INR)
1.38
1.63
1.06
Adjusted ROCE %
47.0%
45.7%
41.6%
FY'23
FY'24
TTM Dec'24
FY'23
FY'24
TTM Dec'24
Cash Conversion (%)
82.0%
68.2%
87.2%
70.8%
94.0%
82.5%
₹22,863
2.19x
Net Debt
₹21,678
1.85x
₹25,000
₹20,000
₹15,000
₹10,000
₹5,000
₹0
2.50
2.00
1.50
1.00
0.50
-
₹7,924
0.55x
FY'23
FY'24
YTD Dec'24
FY'23
FY'24
TTM Dec'24
OCF %
FCF %
Net Debt (in INR Million)
Net Debt to Adjusted EBITDA
Adjusted EPS is Adjusted PAT divided by weighted average number of equity shares Adjusted ROCE is Adjusted PAT plus Interest cost divided by capital employed (Assets excluding goodwill and intangibles less current liabilities) Net Debt is Borrowing plus lease liabilities less Cash and Cash equivalent. Borrowing doesn’t include accrued interest
12
Q3 & YTD Dec FY25 Consolidated Financials
Amt in INR M
Particulars
Revenue from Operation
Other Income
Employee benefits expense
Other expenses
Reported EBITDA
Adjusted EBITDA
Adjusted EBITDA %
Q3 FY25 Q2 FY25 Q3 FY24
YoY%
QoQ%
YTD Dec FY25
YTD Dec FY24
YoY%
14,531
13,250
12,602
15.3%
9.7%
40,014
34,704
15.3%
440
153
57
8,620
8,124
7,983
1,988
2,115
2,017
596
234
25,248
21,382
5,652
5,514
4,362
3,165
2,659
64.1%
37.8%
9,710
8,042
20.7%
4,567
3,378
2,730
67.3%
35.2%
11,104
8,527
30.2%
31.4%
25.5%
21.7%
27.8%
24.6%
Adjusted EBITDA excl. other income
4,127
3,224
2,673
54.4%
28.0%
10,508
8,293
26.7%
Adjusted EBITDA excl. other income %
28.4%
24.3%
21.2%
Finance costs
302
297
468
Depreciation and amortisation expenses
1,162
1,264
1,756
26.3%
23.9%
973
3,525
1,422
5,132
Profit Before Tax
Tax Expenses
Reported Profit After Tax
Adjusted PAT
Adjusted PAT %
Adjusted EPS (Basic and Diluted) (Rs)
2,898
1,604
435
565.9%
80.7%
5,212
1,488
250.3%
729
431
2,169
1,173
(271)
706
1,647
7
207.3%
84.9%
3,565
1,481
140.8%
2,626
1,636
1,567
67.6%
60.5%
5,709
4,245
34.5%
18.1%
0.56
12.3%
0.35
12.4%
0.37
14.3%
12.2%
53.5%
60.5%
1.24
0.99
25.4%
* Financials for YTD Dec FY25, Q3 FY25, Q2 FY25 and Q3 FY24 are unaudited
13
Adjustments on EBITDA and PAT
Adj EBITDA Bridge: Q3 FY25
INR Million
Adj EBITDA Bridge: YTD Dec FY25
INR Million
₹4,362
₹120
₹85
₹4,567
₹9,710
₹364
₹1,030
₹11,104
Reported EBITDA
Adj A
Adj B
Adjusted EBITDA
Reported EBITDA
Adj A
Adj B
Adjusted EBITDA
Adj PAT Bridge: Q3 FY25
INR Million
₹2,169
₹88
₹85
₹284
₹2,626
Adj PAT Bridge: YTD Dec FY25
INR Million
₹847
₹5,709
₹1,030
₹3,565
₹267
Reported PAT
Adj A
Adj B
Adj C
Adjusted PAT
Reported PAT
Adj A
Adj B
Adj C
Adjusted PAT
Adj A - Earnouts under acquisition agreements and for PAT it is adjusted for tax Adj B - Share based payment awards and for PAT it is adjusted for tax Adj C - Intangible assets Amortization is amortization of intangible assets acquired pursuant to business combinations and for PAT it is adjusted of tax
14
Go Forward Positions
Amount in INR M
Particulars
Closing Debt position
Debt Repayment
Interest Payment
Share based Payment awards
Earnouts Cost - DCI / Birch
Intangibles Amortisation
FY'25
8,020
2,490
746
1,089
486
1,396
FY'26
5,670
2,350
535
218
348
1,416
FY'27
FY'28
FY'29
5,670
285
133
72
35
1,416
1,416
1,416
* Numbers are based on the current visibility of management and are subject to change. Factors such as new loans, acquisitions, foreign exchange rate or changes in our share-based payment award plan could impact the final figures
15
Balance Sheet as on 31st Dec’24
Amt in INR M
Particulars
Property, plant and equipment
Capital-work-in-progress
Right-of-use assets
Goodwill
Other intangible assets
Trade receivables
Cash and cash equivalents
Deferred tax assets (net)
Other Assets
Total Assets
Equity
Borrowings
Lease liabilities
Trade payables
Other financial liabilities
Deferred tax liabilities (net)
Other Liabilities
Total Liabilities
Dec'24
3,636
0
5,609
57,731
19,369
11,452
7,263
1,380
2,815
109,254
81,110
9,324
5,922
2,173
2,585
4,461
3,678
Mar'24
3,832
57
5,665
57,096
20,078
11,813
3,441
1,354
3,305
106,642
64,431
19,335
5,982
2,593
6,587
4,710
3,004
109,254
106,642
Financials for Dec’24 are unaudited. Financials for Mar’24 are Audited
16
Cash Flow – YTD Dec FY25
Amt in INR M
Particulars
Profit before tax for the period/ year Adjustment for Non-Operating and Non-Cash Adjustment for working capital Income taxes paid (net of refunds) Net cash flows generated from operating activities (A) - OCF Acquisition of property, plant and equipment and other intangible assets Free Cash flow (FCF) Payment for business combination, net of cash acquired Others Net cash flows (used in) investing activities (B)
Proceeds from issue of shares by subsidiaries in a related party transaction
Share issue expense (paid)/ reimbursed Repayment of borrowings and lease liabilities Interest paid on borrowings and lease liabilities Net cash flows (used in) financing activities (C) Net increase/ (decrease) in cash and cash equivalents (A+B+C) Cash and cash equivalents at the beginning of the year/period Effect of movement in exchange rates on cash and cash equivalents Cash and cash equivalents at the end of the year/ period Net cash flows generated from operating activities % (OCF on EBITDA) Free Cash flow % (FCF on EBITDA)
YTD Dec FY25
FY'24
5,212 5,394 (470) (1,005) 9,132 (1,122) 8,009 (3,786) 299 (4,609)
3,708
72 (3,501) (1,111) (832) 3,691 3,441 131 7,263 94.0% 82.5%
2,417 8,693 (114) (1,263) 9,733 (1,827) 7,905 (3,010) 147 (4,691)
0
(72) (5,546) (1,896) (7,513) (2,471) 5,853 60 3,441 87.2% 70.8%
Financials for YTD Dec FY’25 are unaudited. Financials for FY’24 are Audited
• • Others in investing activities include Proceeds from sale of property, plant and equipment and other intangible assets and Proceeds from maturity of
derivative assets/liabilities, (net) and Interest received
17
Thank You